European guidelines on peri-operative venous thromboembolism prophylaxis: first update.
ESAIC · 2024 · Europe
Source and licence
- Authors
- Kari A.O. Tikkinen, Rufus Cartwright, Anders Gadegaard Jensen et al.
- Title
- European guidelines on peri-operative venous thromboembolism prophylaxis: first update.
- Journal
- European Journal of Anaesthesiology, 2024
- Licence
- CC BY 4.0
- Changes
- Verbatim excerpts; formatting adapted
Full text retrieved 2026-10-27 from Europe PMC · PMC11224558
Licence statement of the original publication
This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
This page reproduces excerpts of the original publication; the original is authoritative. It has not been reviewed by a physician, does not state a recommendation of Medelix and does not replace medical advice. The guideline may have been updated since.
Open the original publication →Full text on Europe PMC
Recommendations
Verbatim, with grade of recommendation or strength of consensus where given.
- Recommendation 1• In all patients undergoing ambulatory day surgery (e.g. circumcision, vasectomy, hydrocoelectomy and ureteroscopy), the Panel recommends against use of pharmacological prophylaxis (Grade 1B), and against use of mechanical prophylaxisGrade 1B
- Recommendation 2• In all patients undergoing open radical cystectomy, or open radical prostatectomy with extended lymphadenectomy, the Panel recommends use of pharmacological prophylaxis (Grade 1A or Grade 1B, depending on risk stratum), and suggests use of mechanical prophylaxisGrade 2C
- Recommendation 3• In patients undergoing most other urological procedures, the risk prediction varies by surgical procedure and patient factors and a more detailed approach is preferred.
Principle 1
- The Panel recommends starting thromboprophylaxis on post operative day 1 compared with presurgery.
Principle 2
- The Panel recommends continuing thromboprophylaxis for an extended period of 2 to 4 weeks when pharmacological thromboprophylaxis is used.
Principle 3
- The Panel recommends that low-molecular-weight heparin (LMWH) can be used and suggests that direct oral anticoagulants (DOAC) may be used for pharmacological thromboprophylaxis.
Contents of the original publication
The section headings of the original.
- Introduction
- Recommendation 1
- Recommendation 2
- Recommendation 3
- Principle 1
- Principle 2
- Principle 3
A question about this guideline?
Medelix answers clinical questions from guidelines and studies – every statement with its source.
Are you the rights holder and object to this reproduction? Write to contact@medelix.ai and we will take the page down promptly. Imprint